
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| LH(L) | 214 | 38.1% | -0.57 | 144 | 45.1% |
| PLP(L) | 176 | 31.4% | -1.21 | 76 | 23.8% |
| SCL(L) | 151 | 26.9% | -0.75 | 90 | 28.2% |
| SLP(L) | 8 | 1.4% | -3.00 | 1 | 0.3% |
| CentralBrain-unspecified | 8 | 1.4% | -3.00 | 1 | 0.3% |
| CA(L) | 1 | 0.2% | 2.81 | 7 | 2.2% |
| Optic-unspecified(L) | 3 | 0.5% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns LHPV2a2 | % In | CV |
|---|---|---|---|---|---|
| WEDPN3 (L) | 3 | GABA | 53 | 9.8% | 0.1 |
| M_l2PNl23 (L) | 1 | ACh | 47 | 8.7% | 0.0 |
| M_ilPNm90 (L) | 1 | ACh | 42 | 7.8% | 0.0 |
| M_l2PNm15 (L) | 1 | ACh | 39 | 7.2% | 0.0 |
| mALB1 (R) | 1 | GABA | 38 | 7.0% | 0.0 |
| M_ilPNm90 (R) | 1 | ACh | 27 | 5.0% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 22 | 4.1% | 0.0 |
| WEDPN2B_b (L) | 1 | GABA | 21 | 3.9% | 0.0 |
| M_lPNm11D (L) | 5 | ACh | 21 | 3.9% | 0.8 |
| OA-VUMa2 (M) | 2 | OA | 19 | 3.5% | 0.4 |
| M_smPN6t2 (R) | 1 | GABA | 13 | 2.4% | 0.0 |
| LHPV6q1 (R) | 1 | unc | 12 | 2.2% | 0.0 |
| M_lPNm11C (L) | 1 | ACh | 11 | 2.0% | 0.0 |
| LHCENT5 (L) | 1 | GABA | 11 | 2.0% | 0.0 |
| LHCENT4 (L) | 1 | Glu | 11 | 2.0% | 0.0 |
| VP1m_l2PN (L) | 1 | ACh | 10 | 1.8% | 0.0 |
| LHPV6q1 (L) | 1 | unc | 8 | 1.5% | 0.0 |
| WEDPN2A (L) | 3 | GABA | 8 | 1.5% | 0.5 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 5 | 0.9% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 5 | 0.9% | 0.0 |
| LoVC20 (R) | 1 | GABA | 5 | 0.9% | 0.0 |
| SMP142 (L) | 1 | unc | 4 | 0.7% | 0.0 |
| WEDPN2B_a (L) | 1 | GABA | 4 | 0.7% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 4 | 0.7% | 0.0 |
| LHAV3p1 (L) | 1 | Glu | 4 | 0.7% | 0.0 |
| mALB2 (R) | 1 | GABA | 4 | 0.7% | 0.0 |
| SMP145 (L) | 1 | unc | 3 | 0.6% | 0.0 |
| M_lPNm13 (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| LHPD5f1 (L) | 1 | Glu | 3 | 0.6% | 0.0 |
| PPL202 (L) | 1 | DA | 3 | 0.6% | 0.0 |
| PPL203 (L) | 1 | unc | 3 | 0.6% | 0.0 |
| VP2_adPN (L) | 1 | ACh | 3 | 0.6% | 0.0 |
| M_vPNml72 (L) | 2 | GABA | 3 | 0.6% | 0.3 |
| PLP159 (L) | 2 | GABA | 3 | 0.6% | 0.3 |
| VA1v_vPN (L) | 2 | GABA | 3 | 0.6% | 0.3 |
| CB0656 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LHPD5c1 (L) | 1 | Glu | 2 | 0.4% | 0.0 |
| CB1055 (R) | 1 | GABA | 2 | 0.4% | 0.0 |
| VP2+Z_lvPN (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| VP1d_il2PN (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| WED092 (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| VL1_ilPN (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| LoVC18 (L) | 1 | DA | 2 | 0.4% | 0.0 |
| PPL201 (L) | 1 | DA | 2 | 0.4% | 0.0 |
| VL1_ilPN (L) | 1 | ACh | 2 | 0.4% | 0.0 |
| LHPV5m1 (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| LHPV2g1 (L) | 2 | ACh | 2 | 0.4% | 0.0 |
| SLP438 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| AVLP487 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| SLP056 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHAV3e2 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV1c2 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP145 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| LHAV3e4_a (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_imPNl92 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| VL1_vPN (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHPV3a1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| WEDPN11 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPV2c1_a (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| LHAV7a5 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB1874 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPD2a6 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPV6h1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAD1b2_d (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV5j1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP043 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPV8c1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_lPNm11A (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHAV2a3 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPV6k2 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPD3c1 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| VP2_l2PN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| CB0650 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| LHPV2a1_c (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| M_vPNml52 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| M_vPNml51 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| GNG461 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| WED092 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| V_l2PN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| M_vPNml55 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| M_imPNl92 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP457 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| LHAV2d1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LHPD4c1 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| 5-HTPMPV01 (R) | 1 | 5-HT | 1 | 0.2% | 0.0 |
| V_ilPN (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 1 | 0.2% | 0.0 |
| V_ilPN (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| downstream partner | # | NT | conns LHPV2a2 | % Out | CV |
|---|---|---|---|---|---|
| M_l2PNm15 (L) | 1 | ACh | 88 | 10.2% | 0.0 |
| M_l2PNl23 (L) | 1 | ACh | 61 | 7.1% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 44 | 5.1% | 0.0 |
| VP1m_l2PN (L) | 1 | ACh | 39 | 4.5% | 0.0 |
| LHPV6g1 (L) | 1 | Glu | 32 | 3.7% | 0.0 |
| V_l2PN (L) | 1 | ACh | 28 | 3.3% | 0.0 |
| VP1m+VP2_lvPN2 (L) | 2 | ACh | 25 | 2.9% | 0.7 |
| LHAV3p1 (L) | 1 | Glu | 20 | 2.3% | 0.0 |
| CB1300 (L) | 2 | ACh | 20 | 2.3% | 0.2 |
| LHPV5m1 (L) | 2 | ACh | 19 | 2.2% | 0.2 |
| LHAV2b2_b (L) | 2 | ACh | 19 | 2.2% | 0.1 |
| VP2_adPN (L) | 1 | ACh | 17 | 2.0% | 0.0 |
| LHPD5c1 (L) | 1 | Glu | 16 | 1.9% | 0.0 |
| LHAV2d1 (L) | 1 | ACh | 15 | 1.7% | 0.0 |
| mALB1 (R) | 1 | GABA | 14 | 1.6% | 0.0 |
| SLP456 (L) | 1 | ACh | 13 | 1.5% | 0.0 |
| VP5+Z_adPN (L) | 1 | ACh | 13 | 1.5% | 0.0 |
| SLP314 (L) | 3 | Glu | 13 | 1.5% | 0.8 |
| M_l2PNl22 (L) | 1 | ACh | 12 | 1.4% | 0.0 |
| LAL183 (R) | 1 | ACh | 12 | 1.4% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 12 | 1.4% | 0.0 |
| LHAV7a5 (L) | 2 | Glu | 12 | 1.4% | 0.5 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 11 | 1.3% | 0.0 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 10 | 1.2% | 0.0 |
| LHAV4i1 (L) | 2 | GABA | 10 | 1.2% | 0.4 |
| OA-VUMa3 (M) | 1 | OA | 9 | 1.0% | 0.0 |
| LHPV6p1 (L) | 1 | Glu | 8 | 0.9% | 0.0 |
| LHAV2b2_d (L) | 1 | ACh | 8 | 0.9% | 0.0 |
| VL1_ilPN (R) | 1 | ACh | 8 | 0.9% | 0.0 |
| LHPV2a3 (L) | 2 | GABA | 8 | 0.9% | 0.8 |
| DN1a (L) | 2 | Glu | 8 | 0.9% | 0.0 |
| VL1_ilPN (L) | 1 | ACh | 7 | 0.8% | 0.0 |
| CB1901 (L) | 4 | ACh | 7 | 0.8% | 0.5 |
| LHPV1c2 (R) | 1 | ACh | 6 | 0.7% | 0.0 |
| M_smPN6t2 (R) | 1 | GABA | 6 | 0.7% | 0.0 |
| V_ilPN (L) | 1 | ACh | 6 | 0.7% | 0.0 |
| PLP130 (L) | 1 | ACh | 5 | 0.6% | 0.0 |
| LHAD1f3_b (L) | 1 | Glu | 5 | 0.6% | 0.0 |
| LHPV2c1_a (L) | 1 | GABA | 5 | 0.6% | 0.0 |
| VP2+_adPN (L) | 1 | ACh | 5 | 0.6% | 0.0 |
| M_lvPNm48 (L) | 1 | ACh | 5 | 0.6% | 0.0 |
| LHPV4j2 (L) | 1 | Glu | 5 | 0.6% | 0.0 |
| M_lPNm11D (L) | 2 | ACh | 5 | 0.6% | 0.2 |
| LHAV3e2 (L) | 2 | ACh | 5 | 0.6% | 0.2 |
| LHPV5l1 (L) | 1 | ACh | 4 | 0.5% | 0.0 |
| SLP313 (L) | 1 | Glu | 4 | 0.5% | 0.0 |
| VP1d_il2PN (R) | 1 | ACh | 4 | 0.5% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 4 | 0.5% | 0.0 |
| CB4208 (L) | 2 | ACh | 4 | 0.5% | 0.5 |
| SLP080 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| SLP160 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| LHPV5b4 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| LHPD3c1 (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| VP2_l2PN (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| LHAV3o1 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| SLP460 (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| SMP531 (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| CL021 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| V_ilPN (R) | 1 | ACh | 3 | 0.3% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 3 | 0.3% | 0.0 |
| LHPV4c1_c (L) | 2 | Glu | 3 | 0.3% | 0.3 |
| CB1326 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LHAV2b5 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LHPV5c3 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| SIP042_a (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| CB2185 (L) | 1 | unc | 2 | 0.2% | 0.0 |
| SMP410 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LHAD1f4 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LHPV7a2 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| CB3479 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| CB3016 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| CB2733 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LHAV2b4 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| SLP256 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| M_lPNm11C (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LHAV3g2 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| CL359 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LHPV4e1 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| LHPV2a1_e (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| VP1d_il2PN (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LHAV2k8 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| GNG517 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| LHPV1c2 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| PPL201 (L) | 1 | DA | 2 | 0.2% | 0.0 |
| LHPV5b1 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| LHPD2c2 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| LHPV2a1_c (L) | 2 | GABA | 2 | 0.2% | 0.0 |
| LHPV4c1_b (L) | 2 | Glu | 2 | 0.2% | 0.0 |
| PLP066 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV6b1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB3141 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHCENT2 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| mALB3 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| PLP097 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VL1_vPN (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CL364 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP065 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2c2 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LHAV8a1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP322 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1060 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV2b8 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP312 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV6h1_b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV4b2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHAV2g6 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP384 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV6f1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP361 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV8c1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV1a4 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2c5 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| CB1276 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV6c1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2g1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB2786 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPD2a6 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP160 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CL142 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHAV1f1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP158 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL234 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPD2c1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV3e1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV10a1a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP382 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV2i2_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV2b2_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV5a4_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MB-C1 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| SLP034 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP123 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP183 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHCENT13_b (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| M_smPNm1 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHAV3f1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| PPL203 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| aMe20 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP257 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.1% | 0.0 |
| LHAV2p1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP457 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LHPV6q1 (L) | 1 | unc | 1 | 0.1% | 0.0 |